Chawla S, Shringarpure K, Modi B, Sharma R, Rewari B B, Shah A N, Verma P B, Dongre A R, Kumar A M V
Gujarat State AIDS Control Society, Health and Family Welfare Department, Government of Gujarat, Ahmedabad, India.
Department of Community Medicine, Government Medical College and SSG Hospital, Vadodara, India.
Public Health Action. 2017 Sep 21;7(3):183-192. doi: 10.5588/pha.16.0108.
Five purposively selected antiretroviral therapy (ART) centres in Gujarat, India. To assess the proportion of ART-eligible people living with the human immunodeficiency virus (PLHIV) who were not initiated on ART within 2 months of being recorded as eligible, to identify factors associated with non-initiation and to explore reasons from the provider's perspective. We used a mixed-methods design (triangulation) of 1) a quantitative phase involving record reviews and cohort analysis (Poisson regression) of PLHIV registered during April 2014-March 2015, and 2) a qualitative phase involving one-to-one interviews with 25 providers. Of 2079 ART-eligible PLHIV, 339 (16%) were not started on ART within 2 months. PLHIV with CD4 counts of <350 cells/μl and patients who were labourers, hospitalised, bedridden or registered with certain ART centres were more likely not to be initiated on ART. Qualitative results were categorised into two broad themes: government health system- and patient-related challenges, which validated and complemented the quantitative findings. Several patient subgroups at greater risk of ART non-initiation were identified, along with reasons for risk; this has important programme implications for achieving the UNAIDS 90-90-90 goal, and particularly the second 90 component of having 90% of diagnosed PLHIV start ART.
印度古吉拉特邦五个经过目的抽样选取的抗逆转录病毒疗法(ART)中心。旨在评估符合ART治疗条件的人类免疫缺陷病毒感染者(PLHIV)中,在被记录为符合条件后的2个月内未开始接受ART治疗的比例,确定与未开始治疗相关的因素,并从提供者的角度探究原因。我们采用了混合方法设计(三角测量法):1)定量阶段,对2014年4月至2015年3月期间登记的PLHIV进行记录审查和队列分析(泊松回归);2)定性阶段,对25名提供者进行一对一访谈。在2079名符合ART治疗条件的PLHIV中,339人(16%)在2个月内未开始接受ART治疗。CD4细胞计数<350个/μl的PLHIV以及劳动者、住院患者、卧床患者或在某些ART中心登记的患者更有可能未开始接受ART治疗。定性结果分为两个广泛的主题:政府卫生系统相关挑战和患者相关挑战,这验证并补充了定量研究结果。确定了几个ART治疗未开始风险较高的患者亚组及其风险原因;这对实现联合国艾滋病规划署90-90-90目标,特别是第二个90%的目标(即90%的确诊PLHIV开始接受ART治疗)具有重要的项目意义。